|
|
REVISTA DE MENOPAUSIA
Menopausia y piel - Parte I: Aspectos fisiopatogénicos
Conclusiones
La piel, al igual que otros órganos, posee receptores hormonales, donde éstos se acoplan y realizan funciones importantes. Por tanto, durante períodos de cambios en la producción y en los niveles circulantes de hormonas como la menopausia, se afecta morfológica y funcionalmente. Los diferentes estudios, reportados algunos de ellos en esta revisión, demuestran que la terapia hormonal de reemplazo contribuye a mejorar las deficiencias que se presentan en las distintas capas de la piel, ayudando a mantener el equilibrio que la piel necesita para mantenerse sana y ejercer su función de barrera cutánea apropiada frente a las injurias externas e internas. Aunque para algunos autores los resultados no han sido replicables respecto a los beneficios de la terapia hormonal, el mayor número de estudios, llevados a cabo con un número de pacientes significante, sí lo demuestra, de ahí el valor que tiene este tratamiento.
En una segunda parte, se describirán las manifestaciones clínicas cutáneas que se presentan durante la menopausia y, posteriormente, la respuesta de ellas ante la terapia hormonal.
Bibliografía
1. Sator PG, Schmidt JB, Sator MO, et al. The influence of hormone replacement therapy on skin ageing. A pilot study. Maturitas 2001; 39: 43-55.
2. Brincat MP ed. Hormone replacement therapy and the skin. Parthenon Publishing Group U.K. 2001; 1-17.
3. Schmidt JB, Lindmaier A, Spona J. Hormone receptors in pubic skin of premenopausal and postmenopausal females. Gynecol Obstet Invest 1990; 30: 96-100.
4. Gail AG, Lee NP, Arriola ER. The menopause. The Lancet 1999; 353(9152): 571-80.
5. Oikarinen A. Systemic estrogens have no conclusive beneficial effect on human skin connective tissue. Acta Obstet Gynecol Scand 2000; 79(4): 250-4.
6. Castelo-Branco C. Skin collagen changes related to age, menopause and hormone replacement therapy. En: Brincat MP. Hormone Replacement Therapy and the Skin. Parthenon Publishing Group U.K. 2001; 19-37.
7. Alberts B, Bray D, Lewis J et al, eds. Molecular Biology of The Cell. New York: Garland Publishing.
8. McLean AB, Nicol LA, Hodgins MB. Immunohistochemical localization of estrogen receptors in the vulva and vagina. J Reprod Med 1990; 35: 1015-16.
9. Hodgins MB, Spike RC, Mackie RM, et al. An immunohistochemical study of androgen, oestrogen and progesterone receptors in the vulva and vagina. Br J Obstet Gynaecol 1998; 105: 216-22.
10. Rauramo L, Punnonen R. Wriking einer oralen estrogentherapie mit oestriolsuccinat auf die Aut. Hastierter [Effect of oral oestrogen treatment with estriol succinate on the skin of castrated women]. Z Haut Geschlechtskr 1969; 44: 463-70.
11. Punnonen R. On the effect of astration and peroral estrogen therapy on the skin. Acta Obstet Gynecol Scand 1971; 9 (Suppl 9): 32.
12. Brincat M, Moniz CJ, Studd JW, et al. Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 1985; 92: 256-259.
13. Meschia M, Bruschi F, Amicarelli F, et al. Transdermal hormone replacement therapy and skin in postmenopausal women, a placebo controlled study. Menopause 1994; 1: 79-82.
14. Grosman N, Hvidberg E, Schou J. The effect of oestrogenic treatment on the acid mucopolysaccharide pattern in skin of mice. Acta Pharmacol Toxicol (Copenh) 1971; 30: 458-64.
15. Goldzieher MA. The effects of oestrogens on the senile skin. J Gerontol 1946; 1: 196.
16. Holland EF, Studd JW, Mansell JP, et al. Changes in collagen composition and cross-links in bone and skin of osteoporotic postmenopausal women treated with percutaneous estradiol implants. Obstet Gynaecol 1994; 83: 180-3.
17. Shuster S, Black MM, McVitie E. The influence of age and sex on skin thickness, skin collagen and density. Br J Dermatol 1975; 6: 639-43.
18. Hall DA, Reed FB, Nuki G, et al. The relative effects of age and corticosteroid therapy on the collagen profiles of dermis from subjects with rheumatoid arthritis. Age ageing 1974; 3: 15-22.
19. Haapasaari KM, Raudaskoski T, Kallioinen M, et al. Systemic therapy with estrogen or estrogen with progestin has no effect on skin collagen in postmenopausal women. Maturitas 1997; 27: 153-62.
20. Brincat M, Moniz CF, Studd JW, et al. Sex hormones and skin collagen content in postmenopausal women. Br Med J (Clin Res Ed) 1983; 287: 1337-8.
21. Brincat M, Versi E, Moniz CF, et al. Skin collagen changes in postmenopausal women receiving different regimens of estrogen therapy. Obstet Gynecol 1987; 70: 123-7.
22. Savvas M, Bishop J, Laurent G, et al. Type III collagen content in the skin of postmenopausal women receiving oestradiol and testosterone implants. Br J Obstet Gynaecol 1993; 100: 154-6.
23. Kohn RR, Schnider SL. Collagen changes in aging skin. En Balin AK, Kligman AM eds. Aging and the skin. New York: Raven Press 1989; 121-42.
24. Monnier VM, Cerami A. Nonenzymatic browning in vivo : possible process for aging of long - lived proteins. Science 1981; 211: 491-3.
25. Gruber C, Huber J. Capillary blood flow in the skin. En: Brincat MP. Hormone Replacement therapy and the Skin Parthenon Publishing 2001; 77-84.
26. Johnson JM, Proppe DW. Cardiovascular adjustments to heat stress. En: Handbook of Physiology. Environmental Physiology. 1st ed. Bethesda, MD: American Physiology Society, 1996: 215-44.
27. Haenggi W, Linder HR, Birkhaeuser MH, et al. Microscopic findings of the nail-fold capillaries_dependence on menopausal status and hormone replacement therapy. Maturitas 1995; 22: 37-46.
28. Arora S, Veves A, Caballaro AE, et al. Estrogen improves endotelial function. J Vasc Surg 1998; 27: 1141-6; discusión 1147.
29. Stephenson LA, Kolka MA. Thermoregulation in women. Exerc Sport Sci Rev 1993; 21: 231-62.
30. Brooks Asplund EM, Kenney WL. Chronic hormone replacement therapy does not alter resting or maximal skin blood flow. J Appl Physiol 1998; 85: 505-10.
31. Sudhir K, Esler MD, Jennings GL, et al. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997; 30: 1538-43.
32. Ginsburg J, Hardiman P, O'Reilly B. Peripheral blood flow in menopausal women
who have hot flushes and in those who do not. Br Med J 1989; 298: 1488-90.
33. Oh HS, Smart RC. An estrogen receptor pathway regulates the telogen-anagen hair follicle transition and influences epidermal cell proliferation. Proc Natl Acad Sci USA 1996; 93: 12525-30.
34. Palacios S, Cifuentes I. Hair and hormone replacement therapy. En: Brincat MP. Parthenon Publishing UK 2001; 145-54.
35. Venning VA, Dawber RPR. Patterned androgenic alopecia in women. J Am Acad Dermatol 1988; 18: 1073-7.
36. Rannevik G, Carlstrom K, Jeppsson S, et al. A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens. Maturitas 1986; 8: 297-307.
37. Laughlin GA, Barret-Connor E, Kritz-Silverstein D, et al. Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo Study. J Clin Ecdocrinol Metab 2000; 85: 645-51.
|
|
